Every Form 4 that Ameren (AEE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AEE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AEE filings page.
Ameren Corporation director Richard J. Harshman reported receiving 1,686 shares of Ameren common stock on January 5, 2026 as an equity award. The shares were acquired at a stated price of $0 per share, consistent with non-cash director compensation. Following this grant, Harshman beneficially owned 22,135 Ameren shares in direct ownership form. A footnote explains that this total includes 71 shares acquired during the fourth quarter of 2025 through reinvested dividends, reflecting ongoing accumulation of stock through the company’s dividend reinvestment process.
Ameren Corp director Rafael Flores reported an amended insider transaction involving Ameren Corp (AEE) common stock. On 11/17/2025, he sold 626 shares of common stock at a weighted average price of $105.32 per share, as part of multiple trades within a price range of $105.21 to $105.38. Following this sale, he beneficially owned 13,772 shares directly, which include 291 shares acquired during the first through third quarters of 2025 through reinvested dividends. The current filing is an amendment to the Form 4 originally filed on November 18, 2025, and is being made to correct the reported number of shares sold, the sale price, and the post-transaction share balance.
Ameren Corporation director Steven O. Vondran reported a stock award received as director compensation. On January 5, 2026, he acquired 1,686 shares of Ameren common stock at a stated price of $0 per share, described as director compensation. After this grant, he beneficially owned 3,597 shares of Ameren common stock, held in direct ownership form. The filing indicates the transaction as an acquisition of non-derivative equity rather than an open-market purchase.
Ameren Corporation executive Shawn E. Schukar reported a transfer of 511 shares of Ameren common stock on December 12, 2025. The transaction, coded "G," shows 511 shares disposed of at a price of $0, reflecting a non-cash movement of shares.
After this transaction, he beneficially owned 56,367 shares of Ameren common stock directly, an amount that includes 62 accrued dividend equivalents from the third quarter of 2025 under the company’s 2022 Omnibus Incentive Compensation Plan. In addition, he held an estimated 3,122 share equivalents through the unitized stock fund in the Ameren Corporation Savings Investment Plan as of November 30, 2025.
Schukar is identified as Chairman and President of a subsidiary of Ameren, and the form was filed as an individual reporting person, highlighting an update to his personal ownership rather than a company-level event.
Ameren Corporation director Steven H. Lipstein reported a change in his Ameren common stock holdings. On 11/26/2025, a Form 4 transaction coded “G” showed the disposition of 2,300 shares of Ameren common stock at a stated price of $0 per share.
Following this transaction, Lipstein beneficially owns 36,176 shares of Ameren common stock in direct ownership form. The filing indicates that the Form 4 was signed by Jonathan T. Shade, Deputy Corporate Secretary of Ameren Corporation, acting as attorney-in-fact for Lipstein.
Ameren Corporation (AEE) director Rafael Flores reported a small stock sale. On 11/17/2025, he sold 225 shares of Ameren common stock at a price of $105.21 per share. After this transaction, he beneficially owned 14,173 Ameren shares in total. This total includes 291 shares acquired during the first through third quarters of 2025 through reinvested dividends.
Ameren Corp (AEE) reported insider transactions by a senior vice president of a subsidiary on 11/14/2025. The officer sold 2,404 shares of common stock at a weighted average price of $104.80, reducing directly held shares to 15,077 and then to 14,957 after a separate disposition of 120 shares coded as a gift. In addition to directly held stock, the officer has 3,018 share equivalents in a 401(k) unitized stock fund as of October 31, 2025, and 683 shares are held indirectly through a spouse. The sale price reflects multiple trades between $104.78 and $104.82.
Ameren Corp (AEE) reported insider activity by its SVP, Finance and CAO, Theresa A. Shaw. On 11/14/2025, she reported a sale of 325 shares of Ameren common stock at $104.77 per share. After this sale, she directly owned 32,942 shares of Ameren common stock.
On the same date, she also reported a separate transaction coded as a gift, transferring 1,432 shares at a price of $0, leaving her with 31,510 shares of directly owned Ameren common stock following the gift. In addition, she has an estimated 884 share equivalents held indirectly through a unitized stock fund in the Ameren Corporation Savings Investment Plan as of October 31, 2025, reflecting retirement-plan related holdings.
Ameren Corporation (AEE) director Richard J. Harshman reported a sale of Ameren common stock. On 11/14/2025, he disposed of 2,500 shares of Ameren common stock at a price of $104.90 per share in an open-market transaction coded "S" for sale. After this transaction, he beneficially owns 20,378 shares of Ameren common stock. The reported holdings include 480 shares that were acquired during the first through third quarters of 2025 through reinvested dividends.
Ameren Corporation reported that officer David M. Feinberg, EVP, General Counsel and Secretary, acquired 3,784 shares of common stock on 11/13/2025 through a grant of restricted stock units under the company’s 2022 Omnibus Incentive Compensation Plan. The award was recorded at a price of $0, reflecting that it is an equity incentive grant rather than a market purchase. Following this grant, Feinberg beneficially owns 3,784 shares directly. The filing notes that these restricted stock units will vest in two equal installments, with 50% vesting on February 28, 2027 and 50% vesting on February 29, 2028, subject to the terms of the plan and the applicable award agreement.
Ameren Corp (AEE) reported an insider transaction by its Sr. Executive VP & CFO. On November 3, 2025, the officer sold 6,500 shares of common stock at $101.44 per share (transaction code S).
After the sale, the officer beneficially owned 198,973 shares directly. In addition, 5,183 share equivalents were held indirectly via a 401(k) unitized stock fund, estimated as of October 31, 2025. The direct holdings figure includes 594 accrued dividend equivalents added during Q3 2025 under the company’s 2022 Omnibus Incentive Compensation Plan.
Ameren Corp (AEE) officer Theresa A. Shaw reported an equity award and updated holdings. On 10/09/2025, she acquired 2,411 restricted stock units at $0 under the 2022 Omnibus Incentive Compensation Plan. These RSUs are scheduled to vest upon the payment date in 2029, which shall be no later than November 15, 2029, subject to plan terms.
Following the reported transaction, Shaw directly owned 33,267 shares of Ameren common stock. The reported amount includes 92 accrued dividend equivalents acquired during the first through third quarters of 2025. She also held 884 share equivalents indirectly in the Ameren Corporation Savings Investment Plan as of September 30, 2025.
Mark C. Lindgren, Executive Vice President and Chief HR Officer of a subsidiary of Ameren Corporation (AEE), reported a sale and current holdings in a Form 4 filing. On 09/12/2025 he sold 3,500 shares of Ameren common stock at $100.89 per share. After the transaction he beneficially owns 42,574 shares, which includes an estimated 1,701 share equivalents in the Ameren Savings Investment Plan as of August 31, 2025, and 48 accrued dividend equivalents from reinvested restricted stock units. The Form 4 was signed by an attorney-in-fact on 09/15/2025. The filing discloses the sale, the composition of holdings, and that dividend reinvestment affected the reported balance.